Singapore, Nov. 18 -- Provectus Algae, the Australian biotechnology startup using advanced biomanufacturing to develop next-generation biological products, has closed a $4.3 million extension to its Series A financing, bringing total Series A funding to more than $14 million.

The Series A was led by At One Ventures, with the extension welcoming Queensland Investment Corporation (QIC) as a new investor, including through the Queensland Government's A$30 million Sowing the Seeds of Farming Innovation Fund, managed by QIC, alongside continued support from existing shareholders.

The additional investment follows a period of significant technical and commercial progress for Provectus Algae, with programmes developed through its Precision Pho...